Related by context. Frequent words. (Click for all words.) 60 Brian Druker 59 DeKosky 59 Cedric Garland 58 Daniel Von Hoff 57 Sidney Kimmel Cancer 57 Pericak Vance 57 Therapeutics TCT scientific 56 Dr. Gregg Fonarow 56 Dr. Judah Folkman 56 Gregg C. Fonarow 56 Sol J. Barer 56 Jeffrey Modell 56 Leroy Hood 56 McKnight Brain 55 Whittemore Peterson 55 LaFerla 55 Biophysical Society 55 Jonsson Comprehensive Cancer 55 Receptos 55 Eric Kandel 54 America HFSA 54 Mikovits 54 LA BioMed 54 Merzenich 54 EnVivo Pharmaceuticals 54 Dr. Von Hoff 54 Banyan Biomarkers 54 Edward Lanphier Sangamo 54 Neuroresearch 53 Immune Tolerance Network 53 Genocea Biosciences 53 Genitourinary Cancers Symposium 53 Zafgen 53 FASgen 53 Irving Weissman 53 Jay Keasling 53 Cedars Sinai Heart 53 Nasser Peyghambarian 53 Eric Topol 53 Amorcyte 53 Seaside Therapeutics 52 Doheny Eye Institute 52 Scripps Translational Science 52 ImmuneRegen BioSciences 52 Alzheimer Disease ICAD 52 Recombinant DNA 52 Elisabeth Kubler Ross 52 Brain Mapping 52 Cardiovascular Imaging 52 NCCN Member Institutions 52 LIAI 52 Quark Pharmaceuticals 52 Pervasis 52 Blanchette Rockefeller Neurosciences 52 Biological Therapy 52 Semafore Pharmaceuticals 52 Agios Pharmaceuticals 52 Molecular Therapeutics 52 Breast Surgeons 52 Prize4Life 52 #:#-#,# CrossRef Medline [002] 52 Roger Tsien 52 Bayhill Therapeutics 52 Semafore 52 Regado Biosciences 52 Antonio Damasio 51 Source MDx 51 UTHealth 51 Folberg 51 Neuropharmacology 51 Skull Base 51 Molecular Cancer 51 Dr. Elias Zerhouni 51 ACNP 51 Dr. Robert Melamede 51 Microbiology Immunology 51 Immunologists 51 Elias Zerhouni 51 Stephen Coggeshall 51 CliniComp Intl 51 Marye Anne Fox 51 NewYork-Presbyterian/Columbia 51 ECTRIMS 51 Kenneth Burman 51 Paul Alivisatos 50 neurogenetics 50 Neurological Disease 50 Robert Sapolsky 50 Clinical Pharmacy 50 Breast Oncology 50 Critical Path Institute 50 Neurochemistry 50 Mayo Clinic Rochester MN 50 AviaraDx 50 Thomas Okarma 50 Neural Engineering 50 Anthony Atala 50 Desmond Hellmann 50 DePinho 50 Sachiko Kuno Ph.D. 50 TIMI Study Group